Sulfisoxazole Diolamine

CHEMBL1200321 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
372.4 g/mol
LogP
Phase
4

Sulfisoxazole diolamine is the diolamine (diethanolamine) salt form of sulfisoxazole used in ophthalmic preparations for bacterial conjunctivitis and other ocular infections caused by susceptible bacteria. See sulfisoxazole for complete pharmacological details.

Masse moléculaire

372,4000 g/mol

TPSA

159,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C.OCCNCCO

InChI

InChI=1S/C11H13N3O3S.C4H11NO2/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10;6-3-1-5-2-4-7/h3-6,14H,12H2,1-2H3;5-7H,1-4H2

Molecular Formula

C15H24N4O5S

HBD / HBA

5 / 9

Liaisons Rotatives

7

Atomes Lourds

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Sulfisoxazole diolamine is the diolamine (diethanolamine) salt form of sulfisoxazole used in ophthalmic preparations for bacterial conjunctivitis and other ocular infections caused by susceptible bacteria. See sulfisoxazole for complete pharmacological details.

Yes, Sulfisoxazole Diolamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200321. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 20287. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.